Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

(2013) Kachit Choopanya et al.   LANCET

MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments

(2013) Craig W. Hendrix et al.   PLoS One

Microbicide clinical trial adherence: insights for introduction

(2013) Cynthia Woodsong et al.   Journal of the International AIDS Society

Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention

(2012) Ariane van der Straten et al.   AIDS

RMP-02/MTN-006: A Phase 1 Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Tenofovir 1% Gel Compared with Oral Tenofovir Disoproxil Fumarate

(2012) Peter A. Anton et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana

(2012) Michael C. Thigpen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

(2012) Jared M. Baeten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preexposure Prophylaxis for HIV Infection among African Women

(2012) Lut Van Damme et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers

(2012) Gaudensia Mutua et al.   PLoS One

Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men

(2012) P. L. Anderson et al.   Science Translational Medicine

HIV and chemoprophylaxis, the importance of considering social structures alongside biomedical and behavioral intervention

(2012) Eric T. Roberts et al.   SOCIAL SCIENCE & MEDICINE

Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women

(2011) Salim S Abdool Karim et al.   AIDS

Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women

(2011) Salim S Abdool Karim et al.   LANCET

Prevention of HIV-1 Infection with Early Antiretroviral Therapy

(2011) Myron S. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Implications of HIV PrEP Trials Results

(2010) Fulvia Veronese et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

(2010) Sheena McCormack et al.   LANCET

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

(2010) Robert M. Grant et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

(2010) Q. Abdool Karim et al.   SCIENCE

A randomised placebo-controlled safety and acceptability trial of PRO 2000 vaginal microbicide gel in sexually active women in Uganda

(2010) A. Kamali et al.   SEXUALLY TRANSMITTED INFECTIONS

Age-disparate and intergenerational sex in southern Africa: the dynamics of hypervulnerability

(2008) Suzanne Leclerc-Madlala   AIDS

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial

(2008) Stephanie Skoler-Karpoff et al.   LANCET

Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission

(2008) Lut Van Damme et al.   NEW ENGLAND JOURNAL OF MEDICINE

SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria

(2008) Paul J. Feldblum et al.   PLoS One

Effectiveness of Cellulose Sulfate Vaginal Gel for the Prevention of HIV Infection: Results of a Phase III Trial in Nigeria

(2008) Vera Halpern et al.   PLoS One